BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37528149)

  • 1. Exome-wide association study of treatment-resistant depression suggests novel treatment targets.
    Shah SB; Peddada TN; Song C; Mensah M; Sung H; Yavi M; Yuan P; Zarate CA; Mickey BJ; Burmeister M; Akula N; McMahon FJ
    Sci Rep; 2023 Aug; 13(1):12467. PubMed ID: 37528149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.
    Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Uher R; Lewis CM; Serretti A
    Transl Psychiatry; 2020 Feb; 10(1):50. PubMed ID: 32066715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing.
    Fabbri C; Pain O; Hagenaars SP; Lewis CM; Serretti A
    Neuropsychopharmacology; 2021 Sep; 46(10):1821-1829. PubMed ID: 34158615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
    Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study.
    Fabbri C; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Riva MA; Lewis CM; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110050. PubMed ID: 32738352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
    Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
    Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome-wide screening identifies novel rare risk variants for major depression disorder.
    Cheng S; Cheng B; Liu L; Yang X; Meng P; Yao Y; Pan C; Zhang J; Li C; Zhang H; Chen Y; Zhang Z; Wen Y; Jia Y; Zhang F
    Mol Psychiatry; 2022 Jul; 27(7):3069-3074. PubMed ID: 35365804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of GRIK4 gene in treatment-resistant depression.
    Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
    Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts.
    Fabbri C; Hagenaars SP; John C; Williams AT; Shrine N; Moles L; Hanscombe KB; Serretti A; Shepherd DJ; Free RC; Wain LV; Tobin MD; Lewis CM
    Mol Psychiatry; 2021 Jul; 26(7):3363-3373. PubMed ID: 33753889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare copy number variation in treatment-resistant major depressive disorder.
    O'Dushlaine C; Ripke S; Ruderfer DM; Hamilton SP; Fava M; Iosifescu DV; Kohane IS; Churchill SE; Castro VM; Clements CC; Blumenthal SR; Murphy SN; Smoller JW; Perlis RH
    Biol Psychiatry; 2014 Oct; 76(7):536-41. PubMed ID: 24529801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.
    Rathod S; Denee T; Eva J; Kerr C; Jacobsen N; Desai M; Baldock L; Young AH
    J Affect Disord; 2022 Mar; 300():551-562. PubMed ID: 34965398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
    Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
    Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.
    Tammiste A; Jiang T; Fischer K; Mägi R; Krjutškov K; Pettai K; Esko T; Li Y; Tansey KE; Carroll LS; Uher R; McGuffin P; Võsa U; Tšernikova N; Saria A; Ng PC; Eller T; Vasar V; Nutt DJ; Maron E; Wang J; Metspalu A
    J Psychopharmacol; 2013 Oct; 27(10):915-20. PubMed ID: 23926243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
    Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
    BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding treatment-resistant depression using "omics" techniques: A systematic review.
    Amasi-Hartoonian N; Pariante CM; Cattaneo A; Sforzini L
    J Affect Disord; 2022 Dec; 318():423-455. PubMed ID: 36103934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.